Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Kovsies beat Pukke at USSA tennis tournament
2010-01-13

 The Kovsies women’s team that participated in last year’s USSA tennis tournament were, from the left, front: Elrien de Villiers and Nicola Dormehl; middle: Rensia Henning and Christine Keyser; back: Jeanne du Plessis and Elizna Barnard.

 

The men who participated in the tournament were, from the left: Willem Steenkamp, PW Holtzhausen, Duke Munro, Janine de Kock (manager), Marnus Kleinhans (coach), Divan Olivier, HB Steyn and Reon Henning.
 

Last year Kovsie tennis concluded on a highlight when the men’s tennis team of the University of the Free State (UFS) won the USSA tournament that was held in Grahamstown for the first time in twenty years. The UFS women’s team also excelled by going through to the final round, where they had to bow the knee before the team of Stellenbosch University.

The result of these excellent achievements was that two of the five players that were selected for the USSA women’s training group were Kovsies. They are Rensia Henning and Christine Keyser. Elrien de Villiers was selected as the player of the tournament but unfortunately she could not be included in the group because she is a Namibian citizen.

The men’s group existed of eight players, of which four are Kovsies. They are Reon Henning, Duke Munro, Willem Steenkamp and PW Holtzhausen.

Members of the USSA training group will participate in training camps, tournaments and trials to prepare for the Confederation of University and College Sport Association (CUCSA) games (where all the Southern Africa countries participate) in Botswana that will take place from 5-11 July 2010. The training group will also participate in the World Student Games in 2011.

The Kovsies men’s team kick-started last year’s USSA tournament by beating the team from the University of Cape Town with 6-1 and later on the same day beating the team from the University of Johannesburg with 5-1. The next day they beat the team from the Tshwane University of Technology with 7-0 and the team of the University of Pretoria with 5-1. According to Ms Janine de Kock from KovsieSport at the UFS this is an excellent achievement, taking into account that Tukkies had ended in second place at the 2008 tournament.

In the semi-finals Kovsies played against the North-West University and beat them with 4-1. After this triumph in the singles matches the organisers decided that the doubles would not be played.

The women’s team won their matches against the Universities of Pretoria, Cape Town, Rhodes, KwaZulu-Natal and the Tshwane University of Technology. The tournament ended with Kovsies and Maties as the only two unbeaten teams and Stellenbosch University walked away with the laurels. The North-West University did not have a women’s team at the tournament at all.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept